Search

Filters
Clear All
  • 15
  • 52
  • 2
  • 647

Phase

  • 1
  • 11
  • 14
  • 47
  • 7
  • 66
  • 6
  • 541
  • 654
  • 299

Found 716 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

D
David Rosmarin
18-100 years
All genders
Phase 2
Interventional
Hidradenitis suppurativa (HS) is a painful skin condition with recurring lumps, abscesses, and tunnels that drain unpleasant fluids, significantly affecting quality of life.What is the purpose of this study?The primary objective of the study is to evaluate the efficacy of anumigilimab administered in Treatment Period A to subjects with moderate …
D
David Rosmarin
18-75 years
All genders
Phase 3
Interventional
What is the purpose of this study?The purpose of this Study is to compare the safety and effects of povorcitinib or placebo on people with nonsegmental vitiligo.
D
David Rosmarin
18-75 years
All genders
Phase 2
Interventional
What is the purpose of this study?This study is being done to find out how safe and how well the drug Tapinarof (VTAMA) works for stopping or treating palmoplantar keratoderma, which is a condition characterized by thickened skin on your palms and soles.  Tapinarof, used as a topical 1% cream, …
D
David Rosmarin
18-70 years
All genders
Phase 1/2
Interventional
Why is this study being done?This study is being done to evaluate the efficacy (how well the drug works), and safety, of rezpegaldesleukin (REZPEG) at different dose levels, as compared to placebo, in adults with severe to very severe Alopecia Areata (AA), and to choose the best dose of REZPEG. …
J
Jessica Parker Metter
18-100 years
Female
Phase 3
Interventional
What is the purpose of this study?The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer …
N
Nasser Hanna, MD
18-100 years
All genders
Phase 2
Interventional
What is the purpose of this study?This research aims to incorporate ctDNA analysis into clinical practice to individualize therapy in patients with stage III NSCLC by moving to a treatment-by-marker based approach (as opposed to treatment based on clinical or radiographic evidence of disease).THIS STUDY IS ENROLLING BY INVITATION ONLY …
M
Mitesh Shah, MD
18-100 years
All genders
Phase 4
Interventional
What is the purpose of this study?This study seeks to explore if GT, given its unique radiobiological and physical characteristics, may permit safe dose escalation and intensification and thereby provide a benefit to newly diagnosed GBM patients in terms of OS and LC when incorporated into the framework of the …
S
Sandeep Batra, MD
12-21 years
All genders
Phase 1/2
Interventional
What is the purpose of this study?This phase I/II trial tests the safety, side effects, and best dose of selinexor given in combination with standard radiation therapy in treating children and young adults with newly diagnosed diffuse intrinsic pontine glioma (DIPG) or high-grade glioma (HGG) with a genetic change called …
S
Shadia Jalal, MD
40-80 years
Male
Interventional
What is the purpose of this study? The purpose of this research study is to: Test whether the TULSA Study Procedure preserves or improves your quality of life (urinary, bowel and sexual functions) at 12 months post-study treatment compared to standard of care (radical prostatectomy). Test how many subjects who …
K
Kathy Miller, MD
18 years and older
All genders
Phase 2
Interventional
What is the purpose of this study?This is a randomized Phase II study of carboplatin monotherapy vs. carboplatin combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast cancer. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients …